“CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025” (2025) Vascular and Endovascular Review, 8(13s), pp. 155–161. doi:10.64149/.